New studies examine links between XMRV and human disease

Evidence supports possible links with cancer but not chronic fatigue syndrome

2010-10-13

(Press-News.org) Xenotropic murine leukemia virus–related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection. (Please see below for links to these articles online.)

In one of the studies, led by Athe Tsibris, MD, investigators from Boston determined XMRV prevalence in a variety of North American clinic populations. The study included healthy subjects, participants with CFS, and participants with chronic immune activation or suppression. Study samples were obtained from adult patients presenting to outpatient clinics or from pre-existing samples at Brigham and Women's Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute. Researchers did not detect XMRV in any of the 293 patients tested, and the investigators did not find an association between XMRV and patients with CFS, chronic immune suppression, or medical conditions associated with chronic immune activation.

Researchers were surprised that they did not detect XMRV in any of the study participants, despite the high prevalence previously reported. A previous study in the United States found evidence of XMRV DNA in 67 percent of subjects with chronic fatigue syndrome (CFS), compared to 3.7 percent of healthy controls. Subsequent studies in Europe, however, were unable to demonstrate the presence of XMRV in CFS subjects or healthy controls.

"The findings suggest that in the population we tested, XMRV is not associated with chronic fatigue syndrome and suggests that differences in PCR technique from study to study do not explain the disparate results seen in XMRV studies of chronic fatigue syndrome," Dr. Tsibris said.

A second study, led by Eleanor Barnes, MD, aimed to detect XMRV in patients with HIV-1 or hepatitis C virus (HCV) infection in the United Kingdom and Switzerland. Because the route of transmission for XMRV has not been established, Dr. Barnes and the researchers tested individuals who were at high risk for contracting blood-borne or sexually transmitted infections. Investigators tested plasma and peripheral blood mononuclear cells to determine if these patients were at risk for XMRV infection.

Investigators did not find XMRV in any of the 230 patients with HIV or HCV infections. According to the researchers, "This study provides the first evidence that if XMRV is a human pathogen, it is not enriched in the blood of patients with HIV or HCV, and by implication it is unlikely to be spread though sexual or blood-borne routes in the UK and Western Europe." In light of these findings, Dr. Barnes noted that further studies are necessary to explore potential transmission routes and determine which members of the population may be at risk.

The possible association between XMRV and human prostate cancer has also been questioned by conflicting studies. Jason T. Kimata, PhD, and investigators from the Baylor College of Medicine looked for XMRV in 144 patients with prostate cancer from the southern United States. Researchers were able to detect XMRV in 22 percent of men with prostate cancer. XMRV was present in both normal and tumor tissue of men with prostate cancer. According to the authors, this suggests that the virus may not specifically target cancer cells for infection and that infection may precede cancer. Dr. Kimata emphasized the need to "continue discussions about XMRV detection assay methodologies, so that discrepancies in the findings of different research groups can be addressed."

In an accompanying editorial, Frank Maldarelli, MD, PhD, and Mary Kearney, PhD, of the National Cancer Institute, pointed out that differences among various studies may be related to a variety of factors, including geography, patient selection, and detection techniques. They noted that these three new studies highlight the need for standardization of detection assays, prospective epidemiological surveys, and sharing of reagents and samples among investigators. Only when this is done in a rigorous fashion will it become clear what role XMRV or related viruses have in human disease.

INFORMATION: Fast Facts: Investigators from Boston did not find an association between XMRV and patients with CFS, chronic immune suppression, or medical conditions associated with chronic immune activation, in a study in the November 15 issue of The Journal of Infectious Diseases. In a second study in the same issue, European researchers did not find XMRV in any of 230 patients infected with HIV or HCV, suggesting that XMRV is unlikely to be transmitted by blood or sexual exposure. Researchers at Baylor College of Medicine detected XMRV in 22 percent of men with prostate cancer, in both tumor and normal tissues, according to a third study in the issue. The studies highlight the need for standardization of XMRV detection assays, prospective epidemiologic surveys of its prevalence, and sharing of reagents and samples among investigators to clarify what role XMRV or related viruses play in human disease.

Note: The three studies and the accompanying editorial are available online:

"Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions" http://www.journals.uchicago.edu/doi/abs/10.1086/657168

"Failure to Detect Xenotropic Murine Leukemia Virus–Related Virus in Blood of Individuals at High Risk of Blood‐Borne Viral Infections" http://www.journals.uchicago.edu/doi/abs/10.1086/657167

"Detection of Xenotropic Murine Leukemia Virus–Related Virus in Normal and Tumor Tissue of Patients from the Southern United States with Prostate Cancer Is Dependent on Specific Polymerase Chain Reaction Conditions" http://www.journals.uchicago.edu/doi/abs/10.1086/656146

"Current Status of Xenotropic Murine Leukemia Virus–Related Retrovirus in Chronic Fatigue Syndrome and Prostate Cancer: Reach for a Scorecard, Not a Prescription Pad" http://www.journals.uchicago.edu/doi/abs/10.1086/657169

Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. It is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Arlington, Va., IDSA is a professional society representing nearly 8,000 physicians and scientists who specialize in infectious diseases. Nested within the IDSA, the HIV Medicine Association (HIVMA) is the professional home for more than 2,600 physicians, scientists and other health care professionals dedicated to the field of HIV/AIDS. HIVMA promotes quality in HIV care and advocates policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.

ELSE PRESS RELEASES FROM THIS DATE:

National committee releases findings on transforming and improving the nursing profession

2010-10-13

CORAL GABLES, FL (October 12, 2010)--Still hampered by workforce shortages and barriers that impede their ranks from delivering health care to the full extent of their education and training, nurses may have gotten the much-needed shot in the arm they need to transform their profession with the release of an Institute of Medicine (IOM) report recommending sweeping changes for improving their profession. The report, the product of a special committee chaired by University of Miami President Donna E. Shalala, recommends everything from higher levels of education and training ...

Blocking an oncogene in liver cancer could be potential therapy option

2010-10-13

COLUMBUS, Ohio – Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy. Without the interference of this gene's function, certain liver cancer cells appear to be protected from the toxic effects of chemotherapy drugs. Blocking the oncogene, called STAT3, prevents a protein from protecting the cells, the research suggests. As a result, more liver cancer cells succumb to treatment. Researchers hope an anti-cancer drug based ...

Metabolic status before pregnancy predicts subsequent gestational diabetes

2010-10-13

OAKLAND, Calif. — Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study in the current issue of the American Journal of Epidemiology. The study suggests that metabolic screening of all women before pregnancy, particularly overweight women, could help identify those more likely to develop gestational diabetes mellitus, known as GDM, in a subsequent pregnancy and help ...

Hospital readmission studies: Influencing factors identified

2010-10-13

In two studies published today in the Journal of Hospital Medicine, the risk factors for readmission to the hospital are examined based upon general medicine inpatients and those with at least two admissions in a six-month period. Alongside clinical factors such as having cancer, chronic diseases such as heart failure or lung disease, or being on high-risk medications, the studies identified other factors which increase the likelihood of a patient being readmitted which could help hospitalists focus in on these groups. In the first study, Nazima Allaudeen, MD, and colleagues ...

Freemake: First CUDA-Supported Free Video Converter

2010-10-13

Freemake Video Converter (http://www.freemake.com/free_video_converter) has recently integrated CUDA technology that can speed up the conversion process by many times. Thus, the videos can be converted to AVI, iPod, iPhone, PSP, and Android devices in a few minutes instead of hours. Freemake Video Converter, version 1.2, features much higher conversion speed and significant gains in performance due to CUDA technology. Therefore, this free converter can be considered one of the pioneers among video tools. Now PC users can convert long videos to HD formats much faster ...

Is infertility more common in women with epilepsy?

2010-10-12

ST. PAUL, Minn. – Women with epilepsy may be more likely to experience infertility, according to new research published in the October 12, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. The study of women in India found that women with epilepsy experienced infertility at more than twice the rate of that found in the general population. The research also found that women who were taking multiple epilepsy drugs were more likely to be infertile than those taking fewer drugs or no drugs for epilepsy. The study involved 375 women ...

You don't have to go out into the woods anymore

2010-10-12

"You don't have to go out into the woods anymore," says tick expert Brian F. Allan, PhD, who just completed a postdoctoral appointment at Washington University in St. Louis. "The deer are bringing tick-borne disease to us." So, it stands to reason that anything deer like, might increase the risk of tick-borne disease for people. The invasive plant bush honeysuckle, for example. Yes, that leafy shrub with the lovely egg-shaped leaves on arching branches, fragrant white or yellow flowers and the dark red berries so attractive to birds. Called bush or Amur honeysuckle, ...

Microbial hair: It's electric

2010-10-12

Some bacteria grow electrical hair that lets them link up in big biological circuits, according to a University of Southern California biophysicist and his collaborators. The finding suggests that microbial colonies may survive, communicate and share energy in part through electrically conducting hairs known as bacterial nanowires. "This is the first measurement of electron transport along biological nanowires produced by bacteria," said Mohamed El-Naggar, assistant professor of physics and astronomy at the USC College of Letters, Arts and Sciences. El-Naggar was ...

Too much light at night at night may lead to obesity, study finds

2010-10-12

COLUMBUS, Ohio – Persistent exposure to light at night may lead to weight gain, even without changing physical activity or eating more food, according to new research in mice. Researchers found that mice exposed to a relatively dim light at night over eight weeks had a body mass gain that was about 50 percent more than other mice that lived in a standard light-dark cycle. "Although there were no differences in activity levels or daily consumption of food, the mice that lived with light at night were getting fatter than the others," said Laura Fonken, lead author of ...

Population trends: Another influence on climate change

2010-10-12

BOULDER--Changes in population growth and composition, including aging and urbanization, could significantly affect global emissions of carbon dioxide over the next 40 years, according to a new study out next week. The research, appearing in Proceedings of the National Academy of Sciences (PNAS), was conducted by an international team of scientists from the National Center for Atmospheric Research (NCAR), the International Institute for Applied Systems Analysis (IIASA), and the National Oceanographic and Atmospheric Administration. It was funded by a European Young Investigator's ...

Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions

Better cardiovascular health in early pregnancy may offset high genetic risk

Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer

Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer

Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology

nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers

Wiley enhances NMR Spectral Library Collection with extensive new databases

[Press-News.org] New studies examine links between XMRV and human disease
Evidence supports possible links with cancer but not chronic fatigue syndrome

New studies examine links between XMRV and human disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: